Table 3—

Logistic regression analysis of predictors of purified protein derivative (PPD) screening offer and completion among human immunodeficiency virus (HIV)-infected patients*

CharacteristicsPPD screening offer#PPD screening completion
Subjects offered PPDSubjects not offered PPDOR95% CIp-valueSubjects completing PPDSubjects non-completing PPDOR95% CIp-value
Subjects n14451851209236
Years of education
AIDS diagnosis
Antiretroviral therapy
  • Data are presented as n (%) unless otherwise stated

  • OR: odds ratio

  • CI: confidence interval

  • ns: nonsignificant

  • AIDS: acquired immune deficiency syndrome

  • *: Sex, age, origin, HIV transmission category, occupation, CD4+ cell count, time since first HIV-positive test, and clinical centres are included in the models

  • #: includes 1,630 patients for whom PPD screening was indicated

  • : includes 1,445 patients to whom PPD screening was offered